Tag: convalescent plasma therapy market forecast

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Convalescent Plasma Therapy Global Market Report 2024 Market from 2024 to 2033?

The convalescent plasma therapy market has also seen rapid growth. It is expected to grow from $0.05 billion in 2023 to $0.05 billion in 2024, reflecting a CAGR of 11.8%. Growth drivers include pandemics and infectious disease outbreaks, immunotherapy research, emergency use authorizations, and increased awareness.

The convalescent plasma therapy market is forecast to grow to $0.08 billion by 2028 at a CAGR of 12.8%. Growth drivers include the development of immunotherapies, regulatory frameworks, global health preparedness, and research into long-term effects.

Claim Your Free Sample of the Global Convalescent Plasma Therapy Global Market Report 2024 Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

What Key Factors Are Fueling the Growth of the Convalescent Plasma Therapy Global Market Report 2024 Market?

The safety and efficacy of convalescent plasma therapy (CPT) in treating COVID-19 patients are expected to drive market growth. Studies have shown that CPT can lead to high recovery rates and reduced mortality, particularly for critically ill patients. In June 2020, Houston Methodist Hospital reported a 76% recovery rate for patients treated with CPT. The positive outcomes of CPT in COVID-19 treatment are likely to contribute to the global growth of the convalescent plasma therapy market.

What Are the Major Segments of the Convalescent Plasma Therapy Global Market Report 2024 Market?

1) By Antibody type: IgM, IgG, IgA

2) By Application: Prophylaxis, Treatment

3) By End-Users: Hospitals & Clinics, Laboratories & Research institutes

What New Trends Are Transforming the Convalescent Plasma Therapy Global Market Report 2024 Market?

The development of antibody-based immunotherapy for COVID-19 is creating opportunities in the convalescent plasma therapy market. For example, Regeneron Pharmaceuticals entered into a partnership with BARDA in August 2023 to advance next-generation COVID-19 monoclonal antibody therapies, boosting the market for antibody-based treatments.

Order Now for Fast Delivery of Your Convalescent Plasma Therapy Global Market Report 2024 Market Report!

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Which Regions Are Driving Growth in the Convalescent Plasma Therapy Global Market Report 2024 Market?

North America was the largest region in the convalescent plasma therapy market in 2023. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Convalescent Plasma Therapy Global Market Report 2024 Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the convalescent plasma therapy global market report 2024 market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Convalescent Plasma Therapy Global Market Report 2024 Market Include

1. Convalescent Plasma Therapy Global Market Report 2024 Market Executive Summary

2. Convalescent Plasma Therapy Global Market Report 2024 Market Segments

3. Convalescent Plasma Therapy Global Market Report 2024 Market Size And Template Market Growth Rate

4. Key Convalescent Plasma Therapy Global Market Report 2024 Market Trends

5. Major Convalescent Plasma Therapy Global Market Report 2024 Market Drivers

……

25. Key Mergers And Acquisitions In The Convalescent Plasma Therapy Global Market Report 2024 Market

26. Top Convalescent Plasma Therapy Global Market Report 2024 Companies

27. Convalescent Plasma Therapy Global Market Report 2024 Market Opportunities And Strategies

28. Convalescent Plasma Therapy Global Market Report 2024 Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Plasma Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Plasma Fractionation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Breakfast Cereal Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/breakfast-cereal-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Convalescent Plasma Therapy Global Market Report 2024, the convalescent plasma therapy market is expected to show significant growth in the forecast period.

The convalescent plasma therapy market has experienced rapid growth, surging from $0.05 billion in 2023 to $0.05 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The historic period’s growth is attributed to pandemics and infectious disease outbreaks, immunotherapy research, emergency use authorization (EUA), patient availability, and heightened clinician and public awareness.

Anticipating Rapid Growth Ahead
The convalescent plasma therapy market is poised for further rapid growth in the coming years, reaching $0.08 billion in 2028, with a projected CAGR of 12.8%. This growth is driven by factors such as evolving pathogens, developments in immunotherapies, regulatory frameworks, global preparedness, and public health initiatives. Key trends in the forecast period include standardized collection and processing, targeted plasma components, personalized treatment approaches, the integration of telemedicine and remote monitoring, and extensive research into long-term effects.

Efficacy and Safety: Cornerstones of Market Growth

Trials Validate Efficacy and Safety
The efficacy and safety demonstrated during clinical trials for Convalescent Plasma Therapy (CPT) in COVID-19 patients play a pivotal role in propelling market growth. Historically, CPT has been of interest for treating infectious diseases like SARS-1, MERS, and the 2009 H1N1 outbreak. According to a systematic review and meta-analysis published in JAMA Network Open, convalescent plasma transfusion was associated with a mortality benefit in immunocompromised COVID-19 patients. The proven safety and efficacy in treating COVID-19 patients will undoubtedly boost the global convalescent plasma therapy market.

Contributions from Major Companies
Leading companies contributing to the growth of the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., and many more. These entities play a crucial role in advancing research, manufacturing, and ensuring the availability of convalescent plasma therapy.

View More On The Convalescent Plasma Therapy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Antibody-Based Therapies: Catalysts for Market Uplift

Innovation with Antibody-Based Immunotherapy
The development of antibody-based immunotherapy represents a significant opportunity for the convalescent plasma therapy market. This therapeutic approach leverages antibodies produced against COVID-19 by donors to enhance the immunity of recipients. Companies are actively engaged in trials, collaborations, and investments in antibody-based COVID-19 therapies. In August 2023, Regeneron Pharmaceuticals Inc. collaborated with the Biomedical Advanced Research and Development Authority (BARDA) to advance the clinical development of next-generation COVID-19 monoclonal antibody therapy. This collaboration, part of Project NextGen by the U.S. Department of Health and Human Services, is expected to drive the market growth as convalescent plasma therapy relies on antibodies.

Segmentation for Precision

The convalescent plasma therapy market is segmented based on antibody type, application, and end-users:

1. Antibody Type:
   • IgM
   • IgG
   • IgA
2. Application:
   • Prophylaxis
   • Treatment
3. End-Users:
   • Hospitals & Clinics
   • Laboratories & Research Institutes

Regional Dynamics: North America Takes the Lead
In 2023, North America emerged as the largest region in the convalescent plasma therapy market. This regional dominance reflects the significant contributions, research advancements, and awareness campaigns conducted in the fight against infectious diseases.

In Conclusion
As the convalescent plasma therapy market continues to evolve, the emphasis on efficacy, safety, and innovative antibody-based therapies is set to drive substantial growth. With major companies at the forefront of research and development, the market’s trajectory is closely tied to global preparedness, regulatory frameworks, and a steadfast commitment to public health initiatives. Stakeholders in the healthcare sector must stay informed about emerging trends and advancements to contribute effectively to the battle against infectious diseases.

Request A Sample Of The Global Convalescent Plasma Therapy Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3233&type=smp